Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellebrite DI (CLBT) Change in Inventory (2020 - 2025)

Historic Change in Inventory for Cellebrite DI (CLBT) over the last 6 years, with Q4 2025 value amounting to $1.3 million.

  • Cellebrite DI's Change in Inventory rose 7211.8% to $1.3 million in Q4 2025 from the same period last year, while for Dec 2025 it was $1.6 million, marking a year-over-year increase of 6619.14%. This contributed to the annual value of $1.6 million for FY2025, which is 6619.14% up from last year.
  • According to the latest figures from Q4 2025, Cellebrite DI's Change in Inventory is $1.3 million, which was up 7211.8% from $882000.0 recorded in Q3 2025.
  • In the past 5 years, Cellebrite DI's Change in Inventory ranged from a high of $1.3 million in Q4 2025 and a low of -$1.7 million during Q4 2021
  • In the last 5 years, Cellebrite DI's Change in Inventory had a median value of -$74000.0 in 2021 and averaged -$131050.0.
  • As far as peak fluctuations go, Cellebrite DI's Change in Inventory tumbled by 356388.89% in 2022, and later surged by 31277.37% in 2023.
  • Quarter analysis of 5 years shows Cellebrite DI's Change in Inventory stood at -$1.7 million in 2021, then skyrocketed by 52.54% to -$812000.0 in 2022, then soared by 257.76% to $1.3 million in 2023, then plummeted by 41.76% to $746000.0 in 2024, then skyrocketed by 72.12% to $1.3 million in 2025.
  • Its Change in Inventory stands at $1.3 million for Q4 2025, versus $882000.0 for Q3 2025 and -$524000.0 for Q2 2025.